GLP-1 drugs , or glucagon-like peptide-1 compounds, represent a remarkable shift in how we treat type 2 diabetes . These new therapies help stimulating the body’s own GLP-1 substance , which promotes https://joycetzlv985372.luwebs.com/42907866/glp-1-a-major-approach-in-glucose-treatment